Webinar: Open questions about nano and face masks

Face masks characterize the public spaces today. Together with other measures, such as social distancing, hand hygiene and contact tracing, masks actively contribute to fight the spread of COVID-19 until vaccines or drugs will be available to treat the disease.

Every crisis creates opportunities. In recent months, many Swiss SMEs have been thinking about what makes a good mask. They have scaled up networking, have been experimenting and tinkering and tried out different ways to develop a sustainable high-tech mask made in Switzerland.

But before a new protective mask can be launched on the market either as a respiratory protection mask (Filtering Facepiece mask or FFP) or a surgical mask, a whole series of tests must be run and certificates to guarantee its quality must be obtained. Protective masks containing nanomaterials in particular must meet the requirements of the EU Medical Devices Regulation of 2017.

Having received an increasing number of enquiries about nanoparticles and face masks, contactpointnano.ch has organized a webinar on Nano and masks.

Program

Sergio Bellucci: The national contactpointnano.ch

Peter Wick: Covid-19, face masks and how nanotechnology can provide solutions

Margrit Widmann:  Classification and regulation of protective masks

Wouter Pronk: Antiviral face masks: Industrial experience

Christoph Geers: The Swiss NanoAnalytics platform

Related articles

The MACRAMÉ Project, a 36-months research and innovation action, funded by the European Commission’s Horizon Europe Framework Programme, commenced its ambitious, collaborative workprogramme on the characterisation and
Crucial results for coron... Empa researcher Peter Wick, Head of the Particles-Biology Interactions Laboratory in St. Gallen and Director of contactpointnano.ch talks to Empa Quarterly about recent antibody studies, which are
Clinam Summit in Basel This year, the 14th European and Global Summit for Clinical Nanomedicine (CLINAM Summit) organized by the European Foundation for Clinical Nanomedicine will take place on 8-11 October
Guidelines: Safe-by-desig... A novel guideline document elaborated by the EU-consortium GoNanoBioMat and presented at the final dissemination event. The GoNanoBioMat framework is designed to elaborate current knowledge to small and medium-sized enterprises
Safe-by-design and EU fun... Contribution of the EU NanoSafetyCluster (NSC), supporting the SbD-study of the European Commission, March 2021 Editors: Andreas Falk, Flemming R. Cassee and Eva Valsami-Jones
Webinar: Open questions a... Face masks characterize the public spaces today. Together with other measures, such as social distancing, hand hygiene and contact tracing, masks actively contribute to fight the spread
Pigments are Nano A webinar by contactpointnano.ch Nanomaterials are something new and innovative, right? Not necessarily: Certain nanomaterials were already in use in the Stone Age, long before mankind invented
Characterizing Nanopartic... Live Webinar, Thursday 19 November, 15:00 (Zürich). Guest speaker Dr. Sandor Balog, Details, Please register for this event using this link
NanoGVA Symposium The 2nd NanoGVA Symposium “Creating the Invisible: the development of nanomedicines” will be hosted by the University of Geneva on October 5-6, 2023. The symposium will deal
Need help with the regist... eREACHNano is a new free web tool focused on helping small and medium-sized companies that may lack sufficient in-house expertise on the regulation covering nanomaterials.